Literature DB >> 8914044

Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.

A Valeri1, L Barisoni, G B Appel, R Seigle, V D'Agati.   

Abstract

A review of all native kidney biopsies at our center from 1974 to 1993 identified 43 cases of idiopathic focal segmental glomerulosclerosis (FSGS) with predominantly collapsing features and lacking evidence of HIV-1 infection or intravenous drug use. No case was identified before 1979 and the incidence of this entity has progressively increased over the past two decades. Compared to 50 age-matched controls of idiopathic FSGS with typical perihilar scars, the group of idiopathic collapsing FSGS displayed black racial predominance, a higher serum creatinine and more severe features of nephrotic syndrome at biopsy. Morphologic features of visceral epithelial cell hypertrophy and hyperplasia, tubular microcysts, tubular epithelial degenerative and regenerative features and interstitial edema were more prevalent and severe in collapsing FSGS. Median time to ESRD was rapid in collapsing FSGS versus controls (13.0 months vs. 62.5 months, P < 0.05). Correlates of progression to ESRD included a higher initial serum creatinine and failure to undergo remission of proteinuria. Both glomerulosclerosis and certain features of tubular damage were independent predictors of the level of renal function at time of biopsy, but not of the rate of progression of renal insufficiency. Although three patients had partial or complete spontaneous remissions, none of 26 patients treated with steroids alone responded. Idiopathic collapsing FSGS is a variant of FSGS with increasing incidence, distinct clinicopathologic features, black racial predominance, a rapidly progressive course and relative steroid resistance.

Entities:  

Mesh:

Year:  1996        PMID: 8914044     DOI: 10.1038/ki.1996.493

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  56 in total

1.  Focal segmental glomerulosclerosis and parvovirus B19.

Authors:  Catalina Sanchez; Andrew Fenves; John Schwartz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

2.  Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients.

Authors:  Ahmed M El-Refaey; Gaurav Kapur; Amrish Jain; Guillermo Hidalgo; Abubakr Imam; Rudolph P Valentini; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2006-12-06       Impact factor: 3.714

Review 3.  Collapsing glomerulopathy in systemic autoimmune disorders: a case occurring in the course of full blown systemic lupus erythematosus.

Authors:  Z Amoura; S Georgin-Lavialle; J Haroche; D Merrien; I Brocheriou; H Beaufils; J-C Piette
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

4.  Fidelity and evolution of recurrent FSGS in renal allografts.

Authors:  Daphne H T IJpelaar; Alton B Farris; Natascha Goemaere; Kerstin Amann; Roel Goldschmeding; Tri Q Nguyen; Evan Farkash; Marius C van den Heuvel; Emile de Heer; Jan A Bruijn; Robert B Colvin; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

5.  Collapsing focal segmental glomerulosclerosis: Current concepts.

Authors:  Muhammed Mubarak
Journal:  World J Nephrol       Date:  2012-04-06

6.  Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

Authors:  Vivette D D'Agati; Joan M Alster; J Charles Jennette; David B Thomas; James Pullman; Daniel A Savino; Arthur H Cohen; Debbie S Gipson; Jennifer J Gassman; Milena K Radeva; Marva M Moxey-Mims; Aaron L Friedman; Frederick J Kaskel; Howard Trachtman; Charles E Alpers; Agnes B Fogo; Tom H Greene; Cynthia C Nast
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

7.  Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.

Authors:  Dominick Santoriello; Syed A Husain; Sacha A De Serres; Andrew S Bomback; Russell J Crew; Elena-Rodica Vasilescu; Geo Serban; Eric S Campenot; Krzysztof Kiryluk; Sumit Mohan; Gregory A Hawkins; Pamela J Hicks; David J Cohen; Jai Radhakrishnan; Michael B Stokes; Glen S Markowitz; Barry I Freedman; Vivette D D'Agati; Ibrahim Batal
Journal:  Kidney Int       Date:  2018-10-02       Impact factor: 10.612

8.  Collapsing Glomerulopathy: A Single Centre Clinicopathologic Study of Seven Years.

Authors:  Kamal V Kanodia; Aruna V Vanikar; Rashmi D Patel; Kamlesh S Suthar; Lovelesh K Nigam; Himanshu V Patel; Vivek Kute; Hargovind L Trivedi
Journal:  J Clin Diagn Res       Date:  2016-04-01

9.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

10.  Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Authors:  Louis-Philippe Laurin; Adil M Gasim; Vimal K Derebail; JulieAnne G McGregor; Jason M Kidd; Susan L Hogan; Caroline J Poulton; Randal K Detwiler; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.